Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

Comparison · United States

Mounjaro vs Zepbound: the same medicine, different approved uses and prices

Paying cash at the starting dose, Mounjaro starts at $499 a month (LillyDirect) and Zepbound at $299 a month (Hims, LillyDirect and Ro.co), checked November 19, 2026. Both are tirzepatide, made by Eli Lilly and injected once a week[1],[3]. The difference is what each is approved for: Mounjaro for type 2 diabetes[1], Zepbound for weight management and for obstructive sleep apnea in adults with obesity[3],[5]. Which suits you is a decision to make with a clinician.

Edited by Gabriel BrocklesbyFounder & EditorFact-checkedLast updated

Label, approval and trial facts checked against the sources listed below on November 17, 2026. Prices read from each seller's own page, last read November 19, 2026. Informational only, not medical advice.

Mounjaro vs Zepbound at a glance

 MounjaroZepbound
Active ingredientTirzepatide (Eli Lilly)[1]Tirzepatide (Eli Lilly)[3]
What it is approved forImproving blood sugar control in adults and children aged 10 and older with type 2 diabetes, alongside diet and exercise; lowering the risk of major heart events in adults with type 2 diabetes at high risk[1]Weight management in adults with obesity, or overweight with a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity[3],[5]
Weight managementNot among its approved uses[1]Approved use[3]
First FDA approvalMay 13, 2022[2]November 8, 2023[4]
FormsSingle-dose pen, single-dose vial, multi-dose vial or KwikPen, injected once a week[1]Single-dose pen, KwikPen or vial, injected once a week[3]
Label dose stepsStarts at 2.5 mg a week, raised by 2.5 mg after at least 4 weeks; up to 15 mg a week in adults (10 mg in children)[1]Starts at 2.5 mg a week, raised in steps of at least 4 weeks; maintenance 5, 10 or 15 mg a week[3]

Mounjaro vs Zepbound cost without insurance

Starting-dose prices, read from each seller's own pricing page. LillyDirect is Lilly's own self-pay pharmacy: it prints no membership and needs a prescription you already hold. The telehealth programs supply the clinician and the prescription and bill a membership on top. A prescription is decided by a licensed clinician and is never guaranteed.

Mounjaro cash prices

Mounjaro cash prices at the starting dose, by seller
SellerFormCash priceMembership or extra feesChecked
LillyDirectManufacturer self-payPen$499/moNo membership printed, prescription requiredNov 18, 2026

Zepbound cash prices

Zepbound cash prices at the starting dose, by seller
SellerFormCash priceMembership or extra feesChecked
HimsTelehealth programSee Hims pricingKwikPen (multi-dose pen)$299/moMembership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
HimsTelehealth programSee Hims pricingVial$299/moMembership $149/mo month to month, $39 the first month, billed separatelyNov 19, 2026
LillyDirectManufacturer self-payKwikPen (multi-dose pen)$299/moNo membership printed, pen needles sold separately, prescription requiredNov 19, 2026
LillyDirectManufacturer self-payVial$299/moNo membership printed, needles and syringes sold separately, prescription requiredNov 19, 2026
Ro.coTelehealth programSee Ro.co pricingKwikPen (multi-dose pen)$299/moMembership $149/mo month to month, $39 the first month, plan rates from $74/mo, billed separatelyNov 19, 2026

Prices are for the starting dose and rise at higher doses. Every brand-name seller and its price history is on the brand-name GLP-1 price chart.

Why one medicine has two brands

Mounjaro was approved first, on May 13, 2022[2]. Its label covers blood sugar control in adults and children aged 10 and older with type 2 diabetes, alongside diet and exercise, and lowering the risk of major heart events in adults with type 2 diabetes who are at high risk[1]. Weight management is not among its approved uses.

Zepbound was approved on November 8, 2023, for weight management[4], and on December 20, 2024, also for moderate to severe obstructive sleep apnea in adults with obesity[5]. In its main trial, SURMOUNT-1, average weight loss at 72 weeks was 15.0%, 19.5% and 20.9% on 5, 10 and 15 mg, against 3.1% on placebo[6]. That is an average, not a prediction for any one person.

Both labels start at 2.5 mg once a week and step up after at least 4 weeks, to a highest dose of 15 mg a week in adults. These are the labels' steps, not advice: your dose is set by your prescriber.

Who sells each online

Online programs that prescribe brand-name tirzepatide, from our price archive. Each runs its own clinician review, and its membership is billed separately. LillyDirect sells both to self-pay patients who already hold a prescription.

Frequently asked questions

Is Mounjaro the same as Zepbound?

They contain the same medicine, tirzepatide, and are both made by Eli Lilly, but they are separate brands with different FDA-approved uses. Mounjaro is approved for type 2 diabetes (blood sugar control, and lowering the risk of major heart events in adults with type 2 diabetes at high risk). Zepbound is approved for weight management and for obstructive sleep apnea in adults with obesity. Both start at 2.5 mg once a week on their labels.

Which is cheaper without insurance, Mounjaro or Zepbound?

At the starting dose, Zepbound costs less than Mounjaro. Paying cash at the starting dose, Mounjaro starts at $499 a month and Zepbound at $299 a month (checked Nov 19, 2026). Both cost more at higher doses.

Is Mounjaro approved for weight loss?

No. Weight management is not among the uses on Mounjaro's label. Zepbound is the tirzepatide brand the FDA approved for weight management. Whether either is right for you is a decision for a licensed clinician.

Do Mounjaro and Zepbound come in the same doses?

Both labels start at 2.5 mg once a week and step up after at least 4 weeks, to a highest dose of 15 mg a week in adults. Mounjaro is also approved for children aged 10 and older with type 2 diabetes, up to 10 mg a week. Your dose is set by your prescriber.

Is compounded tirzepatide the same as Mounjaro or Zepbound?

No. Compounded tirzepatide is made by compounding pharmacies, is not FDA approved and is neither brand. Online programs sell it from $69/mo (Collective, checked Nov 19, 2026); every price we track is on our cheapest tirzepatide list.

Related: Mounjaro cost without insurance, Zepbound cost without insurance, Zepbound vs Wegovy and cheapest compounded tirzepatide online.

Sources

  1. Mounjaro (tirzepatide) injection, US prescribing information, revised August 2026, Eli Lilly. Read November 17, 2026.
  2. Drugs@FDA, NDA 215866 (Mounjaro, Eli Lilly): original approval May 13, 2022. Read November 17, 2026.
  3. Zepbound (tirzepatide) injection, US prescribing information, revised August 2026, DailyMed. Read November 5, 2026.
  4. Drugs@FDA, NDA 217806 (Zepbound, Eli Lilly): original approval November 8, 2023. Read November 5, 2026.
  5. FDA news release, December 20, 2024: FDA Approves First Medication for Obstructive Sleep Apnea (Zepbound). Read November 5, 2026.
  6. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine 2022;387:205-216, PubMed 35658024. Adults with obesity, or overweight with a weight-related complication, without diabetes; 72 weeks. Read November 5, 2026.

Prices: each seller's own pricing page, read on the date shown beside the price.